A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT04227275 · TERMINATED
Trial details
- NCT number
- NCT04227275
- Sponsor
- Tceleron Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-22
- Primary completion
- 2022-11-07
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.